ACKR5 and neoplasm: GPR182−/− mice displayed significantly slower tumor outgrowth than WT and GPR182+/− littermates (Fig. 2a); as a result, tumor mass in GPR182−/− mice at the study endpoint was reduced threeold compared to WT and twofold compared to GPR182+/− mice (Fig. 2b).